WallStSmart
ATRC

AtriCure Inc

NASDAQ: ATRC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$27.34
-4.00% today

Updated 2026-04-29

Market cap
$1.38B
P/E ratio
P/S ratio
2.59x
EPS (TTM)
$-0.24
Dividend yield
52W range
$27 – $43
Volume
0.7M

AtriCure Inc (ATRC) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+94.2%
Last 4 quarters
Revenue YoY growth
+13.1%
Most recent quarter
EPS YoY growth
+175.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.5%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-6.5%
2025-10-29
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-24$0.06+160.5%$31.79$31.19-1.9%
2025-10-29$-0.01+90.9%$36.45$34.09-6.5%
2025-07-28$-0.02+88.0%$31.50$31.73+0.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.10$0.06+160.5%$140.50M+13.1%
2025-09-30$-0.11$-0.01+90.9%$134.27M+15.8%
2025-06-30$-0.17$-0.02+88.0%$136.14M+17.1%
2025-03-31$-0.22$-0.14+37.3%$123.62M+13.6%
2024-12-31$-0.15$-0.08+46.2%$124.28M+16.6%
2024-09-30$-0.19$-0.17+10.5%$115.91M+17.9%
2024-06-30$-0.17$-0.17+0.0%$116.27M+15.2%
2024-03-31$-0.23$-0.28-21.7%$108.85M
2023-12-31$-0.23$-0.21+8.7%$106.54M
2023-09-30$-0.31$-0.20+35.5%$98.29M
2023-06-30$-0.30$-0.11+63.3%$100.92M

Frequently asked questions

Has AtriCure Inc beaten earnings estimates?
AtriCure Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +94.2% over the last 4 quarters.
How does ATRC stock react to earnings?
ATRC stock has moved an average of -2.5% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is AtriCure Inc's revenue growth rate?
AtriCure Inc reported year-over-year revenue growth of +13.1% in its most recent quarter, with EPS growing +175.0% year-over-year.